Oct 16, 2025
Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus. The average market price for this medicine normally hovers around the £5 mark but in late 2019 the drug tariff started to come down from over £10.42...
Sep 24, 2025
At last week’s EMIG Quarterly meeting Donal Markey, Assistant director of Programmes, Transformation and Performance, said that the Irish health service had been reorganised just once while England’s NHS had been reorganised 7 times. As we are in our Silver...
Sep 16, 2025
Leslie Galloway, EMIG Chairman, shared his analysis of VPAG. Here’s Charles’ key takeaways: · The NHS VPAG rebate is £1bn over 3 years and so is a fixed rebate with risk share. · Global Pharma CEOs have asked for lower rebates and a better deal, that...
Sep 16, 2025
Charles Joynson, WaveData MD, decided to have a look at the differences between the average market price for generics and the English drug tariff. He wanted to know if the gap between the two was being squeezed, resulting in some of the misery pharmacists are going...
Sep 16, 2025
Four times over the last 10 years, free market competition between the manufacturers of Olanzapine tablets drove the price to a level where profit was impossible and withdrawal is the only option. When prices decline in the market, the reimbursement drug tariff often...
Sep 11, 2025
Isotrex Gel 0.05% was first launched in the UK by Stiefel Laboratories Ltd on 10 November 2002. It was primarily used to treat acne vulgaris in adolescents and contained isotretinoin, a compound similar to Vitamin A. The first parallel import appeared in the UK in...
